Recruiting

WearLinq eWave

Sponsor:

Wearlinq

Code:

NCT07388355

Conditions

Healthy Adult Participants

Heart Disease

Arrythmia

Cardiac

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

eWave Patch

Study Details

Brief summary:

This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.

Conditions

Healthy Adult Participants

Heart Disease

Arrythmia

Cardiac

Study ID

NCT07388355

Start date

Jul 6, 2026

Status verified date

Jul, 2026

Completion date

Jul 31, 2027

Anticipated

Primary completion date

Jul 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Adult >18 years old and able to consent
  • Capable of using a smartphone app
  • Willing to shave patch area if needed

Exclusion Criteria:

  • Planning to undergo an MRI during the study period
  • Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results
  • Presence of pacemaker, ICD or other implanted electronic devices
  • Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum)
  • Pregnant or intending to become pregnant during the course of the study

Study Design

Enrollment

500 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: 7 Day Study

Participants will receive and apply the WearLinq patch for 7 consecutive days

experimental: Extended Use Cohort

Participants will receive and apply the WearLinq patch for 30 consecutive days

Interventions

eWave Patch

This device is a wearable multi-channel ECG monitoring device for continuous cardiac rhythm tracking.

Primary outcome measure

  • Wear Duration [ Time Frame: 7 Days ]
  • Adverse Events [ Time Frame: 7 Days ]

Central Contacts and Locations

Central contacts

Andrea Brown, MS

408-881-2611abrown@abioclinical.com

Chris Daniel

chris@wearlinq.com

Locations

ABio Clinical Research Partners

Recruiting

New London, North Carolina, United States, 28127

Contacts

Andrea Brown, MS

408-881-2611wearlinqstudy@abioclinical.com

More Information

Sponsor

Wearlinq

Last update posted

Jul 21, 2026

Last verified

Jul, 2026

Keywords

  • Electrocardiogram
  • ECG
  • EKG
  • Cardiac diagnostic

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Wearlinq on 2026-07-21.